Position in CAPR
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$2,694,744
+$1,344,954 QoQ
Shares Held
111,908
+152.0% QoQ
Ownership
0.192%
of shares outstanding
% of Portfolio
0.36%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 63%
Shared 0%
None 37%
Common Shares in CAPR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Pier Capital, LLC holds $37,295,784 across 8 Biotechnology names. CAPR ranks #7 (7.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DRTS |
Alpha Tau Medical Ltd.
|
691,939 | $8,704,592 | |
| 2 | COGT |
Cogent Biosciences, Inc.
|
188,951 | $7,312,403 | |
| 3 | CYTK |
Cytokinetics Inc
|
70,665 | $6,019,951 | |
| 4 | DFTX |
Definium Therapeutics, Inc.
|
88,598 | $4,167,649 | |
| 5 | SPTX |
Seaport Therapeutics, Inc.
|
169,985 | $3,692,074 | |
| 6 | OLMA |
Olema Pharmaceuticals, Inc.
|
220,699 | $2,760,944 | |
| 7 | CAPR |
Capricor Therapeutics, Inc.
This page
|
111,908 | $2,694,744 | |
| 8 | KYMR |
Kymera Therapeutics, Inc.
|
16,948 | $1,943,427 |
All Filings in CAPR
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,694,744 | 111,908 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $1,349,790 | 44,401 | Shares | Sole | 2026-05-14 | |
| 2025-09-30 | $3,580,154 | 496,554 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $3,651,429 | 367,717 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $3,361,177 | 354,181 | Shares | Sole | 2025-05-13 | |
| No filing history on record for this holder in this stock. | ||||||